Back to results
CompletedPhase 3

Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes

NCT00389415

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novartis Pharmaceuticals

Tokyo, Japan

View on ClinicalTrials.gov
Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes — TrialFind